Statin Prescribing Patterns During In-Person and Telemedicine Visits Before and During the COVID-19 Pandemic.

Circ Cardiovasc Qual Outcomes

Penn Medicine Nudge Unit (A.M., M.S.P., S.-H.P., A.J.H., T.O.H., S.A.), University of Pennsylvania, Philadelphia.

Published: October 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530894PMC
http://dx.doi.org/10.1161/CIRCOUTCOMES.121.008266DOI Listing

Publication Analysis

Top Keywords

statin prescribing
4
prescribing patterns
4
patterns in-person
4
in-person telemedicine
4
telemedicine visits
4
visits covid-19
4
covid-19 pandemic
4
statin
1
patterns
1
in-person
1

Similar Publications

Background: Dementia is a growing global public health challenge. Previous meta-analyses have found that systemic medications may modulate dementia risk. We aimed to provide an overview of this evidence.

View Article and Find Full Text PDF

There is an increasing requirement for new therapeutic approaches to address lung inflammation caused by COVID-19. Recent evidence suggests that statins may reduce mortality in patients with respiratory infections. This study aimed to investigate the impact of statin use on COVID-19 outcomes among hospitalized patients at Ohud Hospital and King Salman Medical City (KSMC) in Madinah, Saudi Arabia.

View Article and Find Full Text PDF

Statins are effective in reducing cardiovascular disease (CVD) risk, but adherence rates remain low globally. Understanding and addressing modifiable influences on adherence is key to improving outcomes. Existing reviews have methodological limitations, often failing to integrate qualitative and quantitative data or consider specific barriers to statin adherence.

View Article and Find Full Text PDF

Metabolic alterations are commonly associated with various cancers and are recognized as contributing factors to cancer progression, invasion, and metastasis. Drug repurposing, a strategy in drug discovery, utilizes existing knowledge to recommend established drugs for new indications based on clinical data or biological evidence. This approach is considered a less risky alternative to traditional drug development.

View Article and Find Full Text PDF

Background: Complications of diabetes and its associated comorbidities can cause rapid progression of type II diabetes mellitus (T2DM). It comes at high costs and affects a patient's quality of life. We aim to assess T2DM in KSA, including the demographics, medications, complications, and comorbidities, as it remains an integral part of Vision 2030.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!